These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17331667)

  • 1. Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial.
    van der Wielen GJ; van Putten WL; Incrocci L
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):479-84. PubMed ID: 17331667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial.
    van der Wielen GJ; Hoogeman MS; Dohle GR; van Putten WL; Incrocci L
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):795-800. PubMed ID: 18164862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.
    Selek U; Cheung R; Lii M; Allen P; Steadham RE; Vantreese TR; Little DJ; Rosen II; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1039-46. PubMed ID: 15234037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial.
    Wiegner EA; King CR
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):442-8. PubMed ID: 20137864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.
    Wernicke AG; Valicenti R; Dieva K; Houser C; Pequignot E
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1357-63. PubMed ID: 15590165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference.
    Miller DC; Wei JT; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin PW; Sanda MG
    Urology; 2006 Jul; 68(1):166-71. PubMed ID: 16844457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer?
    Chen CT; Valicenti RK; Lu J; Derose T; Dicker AP; Strup SE; Mulholland SG; Hirsch IH; McGinnis DE; Gomella LG
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):591-5. PubMed ID: 11395224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?
    Macdonald AG; Keyes M; Kruk A; Duncan G; Moravan V; Morris WJ
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):155-63. PubMed ID: 16111584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of sexual function in patients receiving cryosurgery as a primary radical treatment for localized prostate cancer.
    Asterling S; Greene DR
    BJU Int; 2009 Mar; 103(6):788-92. PubMed ID: 18793299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
    Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique: analysis of 542 consecutive patients.
    Jereczek-Fossa BA; Vavassori A; Fodor C; Santoro L; Zerini D; Cattani F; Garibaldi C; Cambria R; Fodor A; Boboc GI; Vitolo V; Ivaldi GB; Musi G; de Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):784-94. PubMed ID: 18191332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erectile function durability following permanent prostate brachytherapy.
    Taira AV; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Kurko BS; Anderson R; Lief JH
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):639-48. PubMed ID: 19303721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tadalafil (Cialis) and erectile dysfunction after radiotherapy for prostate cancer: an open-label extension of a blinded trial.
    Incrocci L; Slob AK; Hop WC
    Urology; 2007 Dec; 70(6):1190-3. PubMed ID: 18158045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer.
    Namiki S; Ishidoya S; Ito A; Tochigi T; Numata I; Narazaki K; Yamada S; Takai Y; Arai Y
    Jpn J Clin Oncol; 2009 Nov; 39(11):732-8. PubMed ID: 19666904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.
    Roach M; Winter K; Michalski JM; Cox JD; Purdy JA; Bosch W; Lin X; Shipley WS
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1351-6. PubMed ID: 15590164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma.
    Brown MW; Brooks JP; Albert PS; Poggi MM
    Prostate Cancer Prostatic Dis; 2007; 10(2):189-93. PubMed ID: 17189954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer.
    Schneider U; Lomax A; Besserer J; Pemler P; Lombriser N; Kaser-Hotz B
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):892-7. PubMed ID: 17459608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer.
    Vora SA; Wong WW; Schild SE; Ezzell GA; Halyard MY
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1053-8. PubMed ID: 17398023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.